Pharmacotherapy of Child and Adolescent Psychiatric Disorders


This book fulfills an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or bipolar disorder, but who are deemed to be at high risk. This is an active area of debate: such children are being treated in certain centers, while others ...

See more details below
Other sellers (Hardcover)
  • All (12) from $57.20   
  • New (10) from $57.20   
  • Used (2) from $85.87   


This book fulfills an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or bipolar disorder, but who are deemed to be at high risk. This is an active area of debate: such children are being treated in certain centers, while others reject this completely. The book addresses the antidepressant controversy, the placebo response and unique strategies for delineating this, and ways to optimize the differential between active medication and placebo. It reviews the impact of recent American Heart Association guidelines for monitoring children on stimulants and other psychotropics. It adheres closely to DSM-IV diagnostic criteria throughout. The book describes the use of newly approved drugs such as Lexapro for treating adolescent depression and the novel compound Intuniv. It covers the TADS and CAMS studies, which evaluated the use of SSRIs alone and in combination with cognitive behavioral therapy for adolescent depression. Other topics include treatment of bipolar disorders, the increasing popularity of generic equivalents, combination pharmacotherapy and the potential dangers of psychotropic medications.
• Third edition of the first ever book published on pediatric psychopharmacology from renowned editors.
• Incorporates current developments with regard to SSRIs, their indications and their safety issues, including possible associated suicidal behavior.
• Addresses concerns about cardiovascular side effects of the new stimulant medications available, and compares to other FDA-approved medications for ADHD.
• Features many tables, figures and pictorials, making it highly accessible and reader friendly.

Read More Show Less

Editorial Reviews

From the Publisher
 “Pharmacotherapy of Child and Adolescent Psychiatric Disorders is a book to have available on your desk, not just in your library.  It provides ready access to the wealth of practical information and insight for the range of health and mental health professionals.  It is highly recommended for trainees and anyone who is prescribing psychotropic medications to the pediatric population and young adults.”  (Journal of Clinical Psychiatry, 7 July 2012)
Doody's Review Service
Reviewer: Jason Chang, MD (Rush University Medical Center)
Description: This multiauthored, theoretical, and practical review of prescribing for child and adolescent psychiatric disorders comes 10 years after the previous edition.
Purpose: It provides a much-needed update of pediatric psychopharmacology and it also addresses some of the current trends and controversies in this area. The book is definitely needed, as child psychopharmacology is an area that is understudied, and a good reliable reference is very important for practitioners. The authors do a good job of meeting their objectives.
Audience: The book is targeted at anyone who prescribes psychiatric medications for children or adolescents — primarily child and adolescent psychiatrists - but it would be particularly useful for trainees, such as fellows and residents. It also would also be useful to pediatricians who are often relied upon to prescribe but undertrained in the specifics, given the shortage of child psychiatrists in the country. The authors are physicians with good experience treating child and adolescent psychiatric cases.
Features: Several chapters on the general theory and principles behind prescribing medications to children open the book. It covers various background concepts, including (interestingly) current topics such as political developments that affect prescribing patterns. The book then systematically reviews each drug class of importance to child psychiatry. It discusses the history, drug mechanisms, prior workup, usage in clinical practice, dosing, and monitoring guidelines thoroughly and clearly. The book always quotes studies, including the most important landmark studies in child psychiatry, and provides good evidence-based support for its statements. The only minor drawback is that given the textbook format, it is not a good quick reference guide for prescribing nor, to be fair, does it claim to be one.
Assessment: This excellent overview of psychopharmacology for children and adolescents makes strong use of studies and evidence to support its information. The newest edition is up to date (and much needed), and addresses relevant real-world issues related to prescribing. It discusses both the theoretical and practical aspects of medication, making it an essential reference for practicing child psychiatrists in an area for which we have very few reliable, useful, and specific resources.
Read More Show Less

Product Details

  • ISBN-13: 9780470973769
  • Publisher: Wiley
  • Publication date: 2/21/2012
  • Edition number: 3
  • Pages: 474
  • Sales rank: 1,129,433
  • Product dimensions: 6.80 (w) x 9.90 (h) x 1.10 (d)

Meet the Author

David Rosenberg MD, Miriam L. Hamburger Endowed Chair of Child Psychiatry and Professor & Chief of Child Psychiatry and Psychology at Wayne State University and the Children's Hospital of Michigan, Detroit, MI , USA

Samuel Gershon MD, Emeritus Professor of Psychiatry, University of Pittsburgh, PA, USA

Read More Show Less

Table of Contents

List of Contributors, xv

Foreword, xix

Chapter 1 Historical Perspectives on Child and Adolescent Psychopharmacology, 1
Samuel Gershon

References, 4

Chapter 2 Pharmacoepidemiology of Psychotropic Medications in Youth, 7
Daniel J. Safer & Julie Magno Zito

Introduction, 7

Prevalence and trends for medications prescribed for ADHD, 8

Nonstimulant medications for ADHD, 11

Antidepressant medication, 11

Antipsychotic medication, 13

Alpha-agonists, 14

Anticonvulsant "mood stabilizers", 15

Concomitant psychotropic medication, 15

Preschool psychotropic medication use, 17

International patterns of psychotropic medication for youth, 17

Conclusion, 18

References, 18

Chapter 3 Off-Label Prescribing of Drugs in Child and Adolescent Psychiatry, 25
C. Lindsay DeVane

Introduction, 25

Extent of off-label prescribing, 27

Need for psychoactive drug treatments for children and adolescents, 31

Legislation supporting pediatric drug development, 33

Recommendations to follow when considering off-label prescribing, 35

References, 36

Chapter 4 The Use of Generic Drugs in Pediatric Psychopharmacology, 39
Richard I. Shader & Christopher-Paul Milne

What is a generic drug?, 39

Why are we discussing generic drugs?, 39

Basic requirements for generic drugs, 40

The status of regulations regarding generic drugs and children, 41

Abbreviated new drug application (ANDA) requirements, 42

Pediatric assessments of adult drugs (history up to current status), 43

Best Pharmaceuticals for Children Act, 44

Pediatric Research Equity Act, 45

Intersection of requirements for generics and pediatric assessment, 46

Future directions, 48

Concluding thoughts, 49

References, 49

Chapter 5 Psychoactive Drug Use in Children: Basic Concepts in Clinical Pharmacology, 51
David J. Edwards

Introduction, 51

Basic concepts in pharmacokinetics, 52

Dosing considerations for psychoactive drugs in children, 55

Summary, 60

References, 60

Chapter 6 Psychostimulants, 65
Steven R. Pliszka

Introduction, 65

Epidemiology of stimulant use, 66

Structure and biochemical mechanism of action, 66

Neuroimaging studies of stimulant effects, 67

Studies of short-term efficacy, 72

Studies of long-term efficacy, 76

Clinical use, 79

Common side-effects, 84

Cardiovascular safety issues, 86

Growth suppression, 88

Substance use and diversion, 88

Comparison with nonstimulant treatment, 89

Treatment of comorbidity, 92

Pharmacogenetics, 93

Conclusions, 94

References, 94

Chapter 7 Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders, 105
Charlotte M. Heleniak, Tejal Kaur, Kareem D. Ghalib & Moira A. Rynn

Tricyclic antidepressants (TCAs), 105

Drug interactions, contraindications, 116

Monoamine oxidase inhibitors (MAOIs), 117

General summary, 122

References, 123

Chapter 8 Selective Serotonin Reuptake Inhibitors (SSRIs), 131
Dara Sakolsky & Boris Birmaher

Pharmacokinetics, 131

Initiation and titration, 133

Indications and efficacy, 134

Adverse effects, 146

Withdrawal, 149

References, 149

Chapter 9 Novel (Atypical) Antidepressants, 155
Heidi R. Bruty, Graham J. Emslie & Paul Croarkin

Novel (atypical) antidepressants, 155

General overview, 155

Bupropion, 157

Duloxetine, 162

Mirtazapine, 164

Trazodone, 166

Venlafaxine, 170

Desvenlafaxine, 173

Alternative treatments, 174

Summary, 175

References, 176

Chapter 10 Antipsychotic Agents, 181
Brieana M. Rowles, John L. Hertzer & Robert L. Findling

Introduction, 181

Chemical properties, 182

Typical antipsychotics, 183

Atypical antipsychotics, 186

Ethical issues: treatment of at-risk populations, 212

Conclusions, 213

References, 213

Chapter 11 Lithium, 221
Garrett M. Sparks & David A. Axelson

Introduction, 221

Pharmacology, 222

Potential mechanisms of action, 222

Evidence for the use of lithium in children and adolescents, 232

Dosing and drug monitoring, 239

Contraindications, precautions, and drug interactions, 242

Side-effects, 246

References, 250

Chapter 12 Anticonvulsants Used in Child and Adolescent Psychiatric Disorders, 261
Mani Pavuluri & Tushita Mayanil

Introduction, 261

Divalproex sodium, 261

Carbamazepine, 271

Oxcarbazepine, 275

Lamotrigine, 279

Gabapentin, 284

Topiramate, 285

Conclusion, 288

References, 288

Chapter 13 Anxiolytics, 301
Barbara J. Coffey & Amanda L. Zwilling

Chemical properties, 301

Indications, 305

Contraindications, 320

Adverse effects, 321

Overdose, 324

Abuse/dependence, 324

Drug interactions, 325

Available preparations and cost, 325

Initiation and maintenance of treatment, 325

Management of specific side-effects, 330

How to withdraw medication, 332

References, 332

Chapter 14 Adrenergic Agents in Child and Adolescent Psychiatry, 341
Lawrence David Scahill

Clonidine and guanfacine, 341

Guanfacine, 349

Beta-blockers, 355

Acknowledgements, 361

References, 361

Chapter 15 Atypical Psychopharmacologic Strategies, 365
Jess Shatkin & Aron Janssen

Opiate antagonists, 365

Memantine, 368

Riluzole, 369

Secretin, 371

Topiramate, 372

Herbal medications and dietary supplements, 373

Ginkgo (Ginkgo biloba), 375

Melatonin, 381

Omega-3 fatty acids, 383

St. John's wort (Hypericum perforatum), 384

Valerian (Valeriana officinalis), 387

Conclusion, 388

References, 389

Chapter 16 Psychopharmacology in Preschool Children, 399
Mini Tandon & Joan Luby

Introduction, 399

Developmental considerations, 400

Rise in psychopharmacology use, 402

Psychotherapy before psychopharmacology, 403

When psychopharmacology may be considered as a first line: pragmatic considerations, 404

Psychopharmacology in preschool disorders: administration and monitoring, 404

Off-label prescribing: special considerations, 407

Use of psychotropics in specific disorders, 408

Summary, 415

References, 415

Chapter 17 Combination Pharmacotherapy for Psychiatric Disorders in Children and Adolescents, 421
Gagan Joshi & Anna M. Georgiopoulos

Bipolar disorder, 422

Major depressive disorder, 429

Attention-deficit hyperactivity disorder, 431

Obsessive-compulsive disorder, 433

Tics and Tourette's syndrome, 434

Pervasive developmental disorders, 434

Conclusion, 434

References, 435

Index, 439

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Terms of Use.
  • - Barnes & reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)